{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:47:50Z","timestamp":1792075670762,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"DOI":"10.1007\/s15010-026-03020-5","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:31:11Z","timestamp":1792074671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum hepcidin as a host-derived biomarker of disease severity and risk stratification in tuberculosis"],"prefix":"10.1007","author":[{"given":"Utkarsh","family":"Kaushik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9524-5278","authenticated-orcid":false,"given":"Durga Shankar","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sojit","family":"Tomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal Krishana","family":"Bohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Kombade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"3020_CR1","unstructured":"WHO. Global tuberculosis report 2025. www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025"},{"key":"3020_CR2","doi-asserted-by":"publisher","first-page":"4212312","DOI":"10.1155\/2023\/4212312","volume":"2023","author":"H Debash","year":"2023","unstructured":"Debash H, Nega J, Bisetegn H, Tesfaw G, Feleke DG, Ebrahim H, et al. Tuberculosis Treatment Outcomes and Its Predictors among Tuberculosis Patients Registered at Tefera Hailu Memorial General Hospital, Sekota Town, Northeast Ethiopia: A Seven-Year Retrospective Study. Can J Infect Dis Med Microbiol. 2023;2023:4212312.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"3020_CR3","doi-asserted-by":"publisher","first-page":"7695","DOI":"10.1038\/s41598-024-58080-0","volume":"14","author":"LW Limenh","year":"2024","unstructured":"Limenh LW, Kasahun AE, Sendekie AK, Seid AM, Mitku ML, Fenta ET, et al. Tuberculosis treatment outcomes and associated factors among tuberculosis patients treated at healthcare facilities of Motta Town, Northwest Ethiopia: a five-year retrospective study. Sci Rep. 2024;14:7695.","journal-title":"Sci Rep"},{"key":"3020_CR4","doi-asserted-by":"publisher","first-page":"e4540","DOI":"10.1097\/MD.0000000000004540","volume":"95","author":"HK Kang","year":"2016","unstructured":"Kang HK, Jeong BH, Lee H, Park HY, Jeon K, Huh HJ, et al. Clinical significance of smear positivity for acid-fast bacilli after \u2265\u20095 months of treatment in patients with drug-susceptible pulmonary tuberculosis. Med (Baltim). 2016;95:e4540.","journal-title":"Med (Baltim)"},{"key":"3020_CR5","doi-asserted-by":"crossref","unstructured":"Shaw JA, Walzl G. Host Biomarkers in Tuberculosis. Cold Spring Harb Perspect Med. 2026:a041833.","DOI":"10.1101\/cshperspect.a041833"},{"key":"3020_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s43856-026-01424-w","volume":"6","author":"B Bauer","year":"2026","unstructured":"Bauer B, Ahmed MIM, Baranov O, Bakuli A, Lin L, Kisinda A, et al. TB sequel consortium. Host response biomarkers of tuberculosis recurrence and treatment failure. Commun Med (Lond). 2026;6:184.","journal-title":"Commun Med (Lond)"},{"key":"3020_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.tips.2014.01.004","volume":"35","author":"P Ruchala","year":"2014","unstructured":"Ruchala P, Nemeth E. The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci. 2014;35:155\u201361.","journal-title":"Trends Pharmacol Sci"},{"key":"3020_CR8","first-page":"1767","volume":"7","author":"MS Palaneeswari","year":"2013","unstructured":"Palaneeswari MS, Ganesh M, Karthikeyan T, Devi AJ, Mythili SV. Hepcidin-minireview. J Clin Diagn Res. 2013;7:1767\u201371.","journal-title":"J Clin Diagn Res"},{"key":"3020_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MOH.0000000000000236","volume":"23","author":"CY Wang","year":"2016","unstructured":"Wang CY, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016;23:189\u201397.","journal-title":"Curr Opin Hematol"},{"key":"3020_CR10","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","volume":"101","author":"E Nemeth","year":"2003","unstructured":"Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461\u20133.","journal-title":"Blood"},{"key":"3020_CR11","first-page":"e27746","volume":"14","author":"T Dasaradhan","year":"2022","unstructured":"Dasaradhan T, Koneti J, Kalluru R, Gadde S, Cherukuri SP, Chikatimalla R. Tuberculosis-Associated Anemia: A Narrative Review. Cureus. 2022;14:e27746.","journal-title":"Cureus"},{"key":"3020_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.medj.2020.10.004","volume":"2","author":"JN Frost","year":"2021","unstructured":"Frost JN, Tan TK, Abbas M, Wideman SK, Bonadonna M, Stoffel NU, et al. Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection. Med. 2021;2:164\u2013e17912.","journal-title":"Med"},{"key":"3020_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijid.2019.06.023","volume":"86","author":"K Tashiro","year":"2019","unstructured":"Tashiro K, Yamamoto M, Ushio R, Kobayashi N, Sato T, Kudo M, et al. Hepcidin exerts a negative immunological effect in pulmonary tuberculosis without HIV co-infection, prolonging the time to culture-negative. Int J Infect Dis. 2019;86:47\u201354.","journal-title":"Int J Infect Dis"},{"key":"3020_CR14","doi-asserted-by":"publisher","first-page":"2539192","DOI":"10.1080\/22221751.2025.2539192","volume":"14","author":"HS Park","year":"2025","unstructured":"Park HS, Choi HG, Jang IT, Pham TA, Jiang Z, Son YJ, et al. Endogenous hepcidin plays an essential role in Mycobacterium tuberculosis Rv1876 antigen-induced antimicrobial activity in macrophages. Emerg Microbes Infect. 2025;14:2539192.","journal-title":"Emerg Microbes Infect"},{"key":"3020_CR15","doi-asserted-by":"publisher","first-page":"101672","DOI":"10.1016\/j.smim.2022.101672","volume":"65","author":"D Tiwari","year":"2023","unstructured":"Tiwari D, Martineau AR. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies. Semin Immunol. 2023;65:101672.","journal-title":"Semin Immunol"},{"key":"3020_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/0970-2113.44121","volume":"25","author":"SK Verma","year":"2008","unstructured":"Verma SK, Dubey AL, Singh PA, Tewerson SL, Sharma D. Adenosine Deaminase (ADA) Level in Tubercular Pleural Effusion. Lung India. 2008;25:109\u201310.","journal-title":"Lung India"},{"key":"3020_CR17","doi-asserted-by":"publisher","first-page":"938544","DOI":"10.3389\/fpubh.2022.938544","volume":"10","author":"R Zhou","year":"2022","unstructured":"Zhou R, Qiu X, Ying J, Yue Y, Ruan T, Yu L, et al. Diagnostic performance of adenosine deaminase for abdominal tuberculosis: A systematic review and meta-analysis. Front Public Health. 2022;10:938544.","journal-title":"Front Public Health"},{"key":"3020_CR18","first-page":"14","volume":"65","author":"DC Raja","year":"2017","unstructured":"Raja DC, Mehrotra S, Agrawal A, Singh A, Sawlani KK. Cardiac Biomarkers and Myocardial Dysfunction in Septicemia. J Assoc Physicians India. 2017;65:14\u20139.","journal-title":"J Assoc Physicians India"},{"key":"3020_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s15010-022-01760-8","volume":"50","author":"PN Essone","year":"2022","unstructured":"Essone PN, Adegbite BR, Mbadinga MJM, Mbouna AV, Lotola-Mougeni F, Alabi A, et al. Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambar\u00e9n\u00e9. Gabon Infect. 2022;50:897\u2013905.","journal-title":"Gabon Infect"},{"key":"3020_CR20","volume-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva, Switzerland: WHO; 2011."},{"key":"3020_CR21","unstructured":"Auerbach M, DeLoughery TG. Diagnosis of iron deficiency and iron deficiency anemia in adults. In: Post TW, editor. UpToDate. Waltham (MA): UpToDate Inc.; 2026 [cited 2026 Jun 11]. Available from: https:\/\/www.uptodate.com\/contents\/diagnosis-of-iron-deficiency-and-iron-deficiency-anemia-in-adults"},{"key":"3020_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/microorganisms11030785","volume":"11","author":"A Nienaber","year":"2023","unstructured":"Nienaber A, Uyoga MA, Dolman-Macleod RC, Malan L. Iron Status and Supplementation during Tuberculosis. Microorganisms. 2023;11:785.","journal-title":"Microorganisms"},{"key":"3020_CR23","doi-asserted-by":"publisher","first-page":"107496","DOI":"10.1016\/j.micpath.2025.107496","volume":"203","author":"T Navidifar","year":"2025","unstructured":"Navidifar T, Meftah E, Baghsheikhi H, Kazemzadeh K, Karimi H, Rezaei N. Dual role of hepcidin in response to pathogens. Microb Pathog. 2025;203:107496. https:\/\/doi.org\/10.1016\/j.micpath.2025.107496.","journal-title":"Microb Pathog"},{"key":"3020_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI200420945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271\u20136.","journal-title":"J Clin Invest"},{"key":"3020_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","volume":"102","author":"T Ganz","year":"2003","unstructured":"Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783\u20138.","journal-title":"Blood"},{"key":"3020_CR26","doi-asserted-by":"publisher","first-page":"e0195985","DOI":"10.1371\/journal.pone.0195985","volume":"13","author":"J Hella","year":"2018","unstructured":"Hella J, Cercamondi CI, Mhimbira F, Sasamalo M, Stoffel N, Zwahlen M, et al. Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin. PLoS ONE. 2018;13:e0195985.","journal-title":"PLoS ONE"},{"key":"3020_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/infdis\/jiv364","volume":"213","author":"AD Kerkhoff","year":"2016","unstructured":"Kerkhoff AD, Meintjes G, Burton R, Vogt M, Wood R, Lawn SD. Relationship Between Blood Concentrations of Hepcidin and Anemia Severity, Mycobacterial Burden, and Mortality Among Patients With HIV-Associated Tuberculosis. J Infect Dis. 2016;213:61\u201370.","journal-title":"J Infect Dis"},{"key":"3020_CR28","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1038\/s41598-018-25480-y","volume":"8","author":"R Abreu","year":"2018","unstructured":"Abreu R, Essler L, Loy A, Quinn F, Giri P. Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages. Sci Rep. 2018;8:7296.","journal-title":"Sci Rep"},{"key":"3020_CR29","doi-asserted-by":"publisher","first-page":"111709","DOI":"10.1016\/j.isci.2024.111709","volume":"28","author":"Z Wang","year":"2024","unstructured":"Wang Z, Guo Z, Zhang Q, Yang C, Shi X, Wen Q, et al. Relationship between iron deficiency and severity of tuberculosis: Influence on T cell subsets. iScience. 2024;28:111709.","journal-title":"iScience"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-03020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-03020-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-03020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:31:15Z","timestamp":1792074675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-03020-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":29,"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-03020-5","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"27 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Institutional ethics committee, AIIMS Jodhpur (Reference no: AIIMS\/IEC\/2024\/5195).","order":2,"name":"Ethics","label":"Ethial approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient included in this report.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}